CKD Prediction in HIV+ Patients
Determines probability of HIV patients developing CKD in the next 5 years, if they take tenofivir or not.
Result:
Please fill out required fields.
Dr. Rebecca Scherzer
About the creator
Rebecca Scherzer, PhD, is an academic administrator at UCSF School of Medicine. She is a research statistician for the Fat Redistribution and Metabolic Change in HIV Infection study and for UCSF's Kidney Health Research Collaborative. Dr. Scherzer research and publications span topics including body composition, metabolic changes, kidney disease and HIV infection-related cardiovascular risk.
To view Dr. Rebecca Scherzer's publications, visit PubMed
Are you Dr. Rebecca Scherzer? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.